. . . . . . . . . . . . . "kin(p(HGNC:PTK2)) -> path(SDIS:metastasis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "In transformed cells and in clinical analyses of human tumors, elevated FAK expression and activity have been correlated with the progression to a highly malignant and metastatic phenotype [6,7,8]. To this end, the possibility that FAK-mediated signaling may promote increased tumorigenicity has generated much interest to determine the mechanisms of FAK activation." . . "Selventa" . . . . "2014-07-03T14:30:22.878+02:00"^^ . . .